Despite de fact that (a) relaxin shares its structure with insulin, (b) it seems to improve insulin resistance, and (c) its circulating levels are altered in diabetes, it is not clear whether or not relaxin could share with insulin the capacity to decrease blood glucose levels. The gene discussed is INS; the disease is diabetes mellitus.